Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Bunick

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
JAMA Dermatology|August 9, 2013
Vegetative plaques and hemorrhagic pustules. IododermaRobert Stavert, Christopher G Bunick, Badri Modi, et al.
Journal of Drugs in Dermatology : JDD|May 6, 2025
Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic DermatitisOmar Alani, David Wang, Samer Wahood, et al.
Environmental Health Perspectives|March 14, 2024
Benzoyl Peroxide Drug Products Form BenzeneKaury Kucera, Nicola Zenzola, Amber Hudspeth, et al.
Human Genomics|January 7, 2022
Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disordersMinh Ho, Brian Thompson, Jeffrey Nicholas Fisk, et al.
The Journal of Investigative Dermatology|March 12, 2015
Crystal Structure of Human Profilaggrin S100 Domain and Identification of Target Proteins Annexin II, Stratifin, and HSP27Christopher G Bunick, Richard B Presland, Owen T Lawrence, et al.
JAAD Case Reports|August 4, 2016
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapyKathleen C Suozzi, Maximilian Stahl, Christine J Ko, et al.
Journal of Dermatological Science|September 7, 2020
Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteinsAlexander J Hinbest, Sa Rang Kim, Sherif A Eldirany, et al.
Pharmaceutics|November 27, 2025
Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current ApplicationsLara Shqair, Iyla Draw, Tala Maya, et al.
American Journal of Clinical Dermatology|November 1, 2025
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 TrialsRobert Bissonnette, Fatima Albreiki, Benjamin D Ehst, et al.
American Journal of Clinical Dermatology|September 27, 2025
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 TrialsRobert Bissonnette, Fatima Albreiki, Benjamin D Ehst, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
JAMA Dermatology|August 9, 2013
Vegetative plaques and hemorrhagic pustules. IododermaRobert Stavert, Christopher G Bunick, Badri Modi, et al.
Journal of Drugs in Dermatology : JDD|May 6, 2025
Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic DermatitisOmar Alani, David Wang, Samer Wahood, et al.
Environmental Health Perspectives|March 14, 2024
Benzoyl Peroxide Drug Products Form BenzeneKaury Kucera, Nicola Zenzola, Amber Hudspeth, et al.
Human Genomics|January 7, 2022
Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disordersMinh Ho, Brian Thompson, Jeffrey Nicholas Fisk, et al.
The Journal of Investigative Dermatology|March 12, 2015
Crystal Structure of Human Profilaggrin S100 Domain and Identification of Target Proteins Annexin II, Stratifin, and HSP27Christopher G Bunick, Richard B Presland, Owen T Lawrence, et al.
JAAD Case Reports|August 4, 2016
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapyKathleen C Suozzi, Maximilian Stahl, Christine J Ko, et al.
Journal of Dermatological Science|September 7, 2020
Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteinsAlexander J Hinbest, Sa Rang Kim, Sherif A Eldirany, et al.
Pharmaceutics|November 27, 2025
Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current ApplicationsLara Shqair, Iyla Draw, Tala Maya, et al.
American Journal of Clinical Dermatology|November 1, 2025
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 TrialsRobert Bissonnette, Fatima Albreiki, Benjamin D Ehst, et al.
American Journal of Clinical Dermatology|September 27, 2025
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 TrialsRobert Bissonnette, Fatima Albreiki, Benjamin D Ehst, et al.
Pageof 16